Monday 8/17 Insider Buying Report: ABCL, BPRN
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At AbCellera Biologics, a filing with the SEC revealed that on Wednesday, Director
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
